O uso irracional e prolongado de benzodiazepínicos como potenciais causadores de demência em idosos

Authors

  • LARISSA MARCHI Centro Universitário Padre Albino UNIFIPA
  • Luís Fernando Piovesan Centro Universitário Padre Albino - UNIFIPA
  • Dallila Brandão dos Santos Bianchi

DOI:

https://doi.org/10.47224/revistamaster.v8i16.459

Keywords:

Benzodiazepínicos, Demência, Doença de Alzheimer, Envelhecimento

Abstract

Benzodiazepines are the most used psychiatric drugs worldwide, having pharmacological properties with sedative, hypnotic, anxiolytic, anticonvulsant and muscle relaxant effects. However, prolonged use may be associated with dementia, especially among the elderly. To investigate the association between dementia and the prolonged use of benzodiazepines in the elderly. A bibliographic review was carried out with a narrative character of articles published in the last ten years (2013 to 2023), using the SciELO, PubMed, BVS and Google Scholar database. The study of the selected bibliographies showed that the use of benzodiazepines among the elderly has a high prevalence. In addition, this type of drugs is not recommended to be used by the elderly, worsening its consequences even more when the treatment is carried out in the long term, aggravating a set of adverse events without showing efficacy in this format of use. Most of the pharmacoepidemiological studies carried out so far have concluded that benzodiazepine users are at increased risk of developing dementia, but the mechanisms by which the increased risk of dementia in the elderly may possibly occur remains unclear. It is important to seek less harmful ways to solve complaints regarding sleep and anxiety in the elderly and to enable health professionals to identify drugs not recommended to use in the elderly and come up with ways to optimize prescriptions. Therefore, there is a need for further studies on the subject, in order to observe the possible risks that exist in the reckless use of benzodiazepines.

 

 

Downloads

Download data is not yet available.

References

ABRAHAM J, GALANTER WL, TOUCHETTE D, XIA Y, HOLZER KJ, LEUNG V et al. Risk factors associated with medication ordering errors. J Am Med Inform Assoc. v. 15;28(1), p.86-94, 2021. DOI: https://doi.org/10.1093/jamia/ocaa264

AL-KURAISHY HM, AL-GAREEB AI, ALSAYEGH AA, ABUSUDAH WF, ALMOHMADI NH, ELDAHSHAN OA et al. Insights on benzodiazepines' potential in Alzheimer's disease. Life Sci. v. 1;320, p. 121532, 2023. DOI: https://doi.org/10.1016/j.lfs.2023.121532

BICCA M, G.; ARGIMON, L. Habilidades cognitivas e uso de benzodiazepínicos em idosas institucionalizadas. Jornal Brasileiro de Psiquiatria. v. 57, n. 2, p. 133-138, mar, 2018. DOI: https://doi.org/10.1590/S0047-20852008000200009

BREWSTER GS, RIEGEL B, GEHRMAN PR. Insomnia in the Older Adult. Sleep Med Clin. v. 17(2), p.233-239, 2022. DOI: https://doi.org/10.1016/j.jsmc.2022.03.004

COCHAR-SOARES, N.; DELINOCENTE, M. L. B.; DATI, L. M. M. Fisiologia do envelhecimento: da plasticidade às consequências cognitivas. Revista Neurociências, v. 29, 2021. DOI: https://doi.org/10.34024/rnc.2021.v29.12447

CORREIA, G. de A. R. et al. Utilização de Benzodiazepínicos e Estratégias Farmacêuticas em Saúde Mental. Saúde em Debate, v. 38, n. 101, p. 393-398, 2014. DOI: https://doi.org/10.5935/0103-1104.20140036

COURET A, GALLINI A, PONCET M, RENOUX A, LAPEYRE-MESTRE M, GARDETTE V. Benzodiazepine dispensing to persons with dementia in france, 2011-2016: a nationwide study. J Am Med Dir Assoc. v. 21(6) p. 830-836, 2020. DOI: https://doi.org/10.1016/j.jamda.2020.02.019

CUNNINHAM, EL; MCGUINNESS, B; HERRON, B; PASSMORE, AP. Dementia: review. Ulster Med J, Reino Unido, v. 84, n. 2, p. 79-87, maio 2015.

DE ALMEIDA MENDES, A K. et al. Uso de benzodiazepínicos em idosos no Brasil. Research, Society and Development, v. 11, n. 2, p. e32511225820-e32511225820, 2022. DOI: https://doi.org/10.33448/rsd-v11i2.25820

DE CARVALHO CORDEIRO, T D. et al. Alterações fisiológicas da visão durante o envelhecimento: percepção de idosos e profissionais. Invest Educ Enferm, v. 39, n. 3, 2021.

FARIA, J. S. S.; ROSSI, S. V.; ANDREATTA, T.; SIMÕES, V. P.; POMBO, B. H.; MOREIRA, R. B. Benzodiazepínicos: revendo o uso para o desuso. Revista de Medicina, [S. l.], v. 98, n. 6, p. 423-426, 2019. DOI: https://doi.org/10.11606/issn.1679-9836.v98i6p423-426

FREIRE MBO, DA SILVA BGC, BERTOLDI AD, FONTANELLA AT, MENGUE SS, RAMOS LR, et al. Utilização de benzodiazepínicos em idosos brasileiros: um estudo de base populacional. Rev Saúde Publica. v. 56,p. 10, 2022. DOI: https://doi.org/10.11606/s1518-8787.2022056003740

GAGE, S. B. de et al. Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ, v. 349, n. g5205, ago./set. 2014. DOI: https://doi.org/10.1136/bmj.g5205

GOES ACJ; REIS LAB; SILVA MBG; KAHLOW BS, SKARE TL. Artrite Reumatóide e qualidade do sono. Rev. Bras reumatol.; v. 57(4), p.294-298, 2017. DOI: https://doi.org/10.1016/j.rbr.2016.06.002

KROENKE K, HIRSCHTRITT ME. Walking the Benzodiazepine High Wire. Psychiatr Serv. v. 1;74(1), p.73-75, 2023. DOI: https://doi.org/10.1176/appi.ps.202100671

MODESTO-LOWE V; JAIN L; RODRIGUES R. Benzodiazepine use: cross-national perspectives. Fam Pract. v. 9;40(1), p.205-206, 2023. DOI: https://doi.org/10.1093/fampra/cmac049

RITVO AD, FOSTER DE, HUFF C, FINLAYSON AJR, SILVERNAIL B, MARTIN PR. Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey. PLoS One. v. 29;18(6), p.e0285584, 2023. DOI: https://doi.org/10.1371/journal.pone.0285584

SAHNI V. A clear ambiguity in oral benzodiazepine prescription practices. Br Dent J. v. 235(1), p.41, 2023. DOI: https://doi.org/10.1038/s41415-023-6062-8

SMITH JT, SAGE M, SZETO H, MYERS LC, LU Y, MARTINEZ A et al. Outcomes after implementation of a benzodiazepine-sparing alcohol withdrawal order set in an integrated health care system. JAMA Netw Open. v. 1;5(2), p. 220158, 2022. DOI: https://doi.org/10.1001/jamanetworkopen.2022.0158

TANGUAY-BERNARD M, LUC M, CARRIER J, FOURNIER L, DUHOUX A, CÔTÉ E, et al. Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon.; v. 4(7), p. e00688, 2018. DOI: https://doi.org/10.1016/j.heliyon.2018.e00688

ZAAL IJ, DEVLIN JW, HAZELBAG M, KLEIN KLOUWENBERG PM, VAN DER KOOI AW, ONG DS. et al. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med. v. 41(12), p.2130-7, 2015. DOI: https://doi.org/10.1007/s00134-015-4063-z

Published

2023-12-14

How to Cite

MARCHI, L.; PIOVESAN, L. F.; BRANDÃO DOS SANTOS BIANCHI, D. O uso irracional e prolongado de benzodiazepínicos como potenciais causadores de demência em idosos. Revista Master - Ensino, Pesquisa e Extensão, [S. l.], v. 8, n. 16, 2023. DOI: 10.47224/revistamaster.v8i16.459. Disponível em: https://revistamaster.emnuvens.com.br/RM/article/view/459. Acesso em: 19 sep. 2024.